Company profile: Cognate BioServices
1.1 - Company Overview
Company description
- Provider of fully integrated contract bioservices, offering full development and cGMP manufacturing services to companies and institutions developing cell-based products. Delivers comprehensive cell and gene therapy CDMO solutions, including development and manufacturing for cell- and gene-mediated cell therapies.
Products and services
- Cell and Gene Therapy CDMO Systems: Fully-integrated CDMO furnishes comprehensive development and cGMP manufacturing services for cell and gene-mediated cell therapies to companies and institutions engaged in cell-based product development
- CGMP Manufacturing Services: cGMP-compliant manufacturing produces cell-based products for companies and institutions, implementing rigorous cGMP standards with highly experienced staff for cell and gene-mediated cell therapies
- Full Development Services: Cell-based development, backed by highest-level scientific and management expertise, architects and advances programs for companies and institutions engaged in cell and gene-mediated cell therapies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cognate BioServices
Ethos Health Communications
HQ: United States
Website
- Description: Provider of medical and marketing communications services, offering medical affairs to analyze complex data and landscapes; KOL data solutions to identify, map, and track thought leader influence; training, learning and development across the product life cycle; pharma marketing for commercialization, launch planning, and multichannel execution; digital opinion leader mapping in healthcare; and scientific communications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ethos Health Communications company profile →
BioVectra
HQ: Canada
Website
- Description: Provider of contract development and manufacturing services for intermediates and active pharmaceutical ingredients, with over 40 years' experience serving global pharmaceutical and biotechnology clients. Capabilities span synthetic organic chemistry, microbial fermentation for biologics (e.g., recombinant insulin), synthetic small molecules, highly potent APIs, bioreagents, and pDNA/mRNA production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioVectra company profile →
GL Chemtec
HQ: Canada
Website
- Description: Provider of custom small-molecule API discovery, process development, scale-up and manufacturing for life sciences; tailored biomedical polymers and hydrogels for drug delivery and medical devices (including silicone hydrogels, functionalized biopolymers, emulsions, synthetic organoids); integrated drug-delivery solutions combining small-molecule chemistry and polymer design; and analytical method development and transfer, stability studies and sample analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GL Chemtec company profile →
Quay Pharma
HQ: Australia
Website
- Description: Provider of contract development, manufacturing and packaging services, with scientific expertise and flexible response to support projects and improve the chances of successful clinical trials. Independent and privately owned.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quay Pharma company profile →
McDougall Scientific
HQ: Canada
Website
- Description: Provider of clinical trial design, statistical analysis, top-tier data management and reporting services as a niche Clinical Research Organization supporting clinical research for pharmaceutical, biotechnology and medical device companies across a variety of therapeutic areas and all phases of clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full McDougall Scientific company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cognate BioServices
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cognate BioServices
2.2 - Growth funds investing in similar companies to Cognate BioServices
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cognate BioServices
4.2 - Public trading comparable groups for Cognate BioServices
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →